CoChat

Identifying CNS-colonizing T cells as potential therapeutic targets to prevent progression of multiple sclerosis

Open access
Kaufmann, Max, Evans, Hayley, Schaupp, Anna-Lena, Engler, Jan Broder, Kaur, Gurman, Willing, Anne, Kursawe, Nina, Schubert, Charlotte, Attfield, Kathrine E., Fugger, Lars, Friese, Manuel A. · 2021 · Med
Cited by 97

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

Background Multiple sclerosis (MS), an autoimmune disease of the central nervous system (CNS), can be suppressed in its early stages but eventually becomes clinically progressive and unresponsive to therapy. Here, we investigate whether the therapeutic resistance of progressive MS can be attributed to chronic immune cell accumulation behind the blood-brain barrier (BBB). Methods We systematically track CNS-homing immune cells in the peripheral blood of 31 MS patients and 31 matched healthy individuals in an integrated analysis of 497,705 single-cell transcriptomes and 355,433 surface protein profiles from 71 samples. Through spatial RNA sequencing, we localize these cells in post mortem brain tissue of 6 progressive MS patients contrasted against 4 control brains (20 samples, 85,000 spot transcriptomes). Findings We identify a specific pathogenic CD161+/lymphotoxin beta (LTB)+ T cell population that resides in brains of progressive MS patients. Intriguingly, our data suggest that the colonization of the CNS by these T cells may begin earlier in the disease course, as they can be mobilized to the blood by usage of the integrin-blocking antibody natalizumab in relapsing-remitting MS patients. Conclusions As a consequence, we lay the groundwork for a therapeutic strategy to deplete CNS-homing T cells before they can fuel treatment-resistant progression. Funding This study was supported by funding from the University Medical Center Hamburg-Eppendorf, the Stifterverband für die Deutsche Wissenschaft, the OAK Foundation, Medical Research Council UK, and Wellcome.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.medj.2021.01.006

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 97

Metadata

Authors
Kaufmann, M., Evans, H., Schaupp, A.-L., Engler, J. B., Kaur, G., Willing, A., Kursawe, N., Schubert, C., Attfield, K. E., Fugger, L., & Friese, M. A.
Venue
Med
Publisher
Elsevier BV
Published
2021-03
Volume
2
Issue
3
Pages
296-312.e8
ISSN
2666-6340 (ISSN-L)
OpenAlex
W3130806873
Cited by
97
References
19
FWCI
9.17
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Identifying CNS-colonizing T cells as potential therapeutic targets to prevent progression of multiple sclerosis. https://app.cochat.ai/papers/10.1016/j.medj.2021.01.006
The paper
Kaufmann, M., Evans, H., Schaupp, A.-L., Engler, J. B., Kaur, G., Willing, A., Kursawe, N., Schubert, C., Attfield, K. E., Fugger, L., & Friese, M. A. (2021). Identifying CNS-colonizing T cells as potential therapeutic targets to prevent progression of multiple sclerosis. Med. https://doi.org/10.1016/j.medj.2021.01.006

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.